Centessa Pharmaceuticals PLC ADR (CNTA) Insider Trading
- $9,101,824.86
- $19,339,012.56
- June 25, 2025
- Saurabh Saha
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
June 1, 2023 | EVP | 6,500 | $4.45 | Sell | $28,925.00 | |
May 24, 2023 | Insider | 8,000 | $4.48 | Sell | $35,840.00 | |
May 1, 2023 | EVP | 6,800 | $4.42 | Sell | $30,056.00 | |
Jan. 4, 2023 | EVP | 6,970 | $3.18 | Sell | $22,164.60 | |
Dec. 1, 2022 | EVP | 9,400 | $3.91 | Sell | $36,754.00 | |
Nov. 1, 2022 | EVP | 9,700 | $4.03 | Sell | $39,091.00 | |
Oct. 3, 2022 | Insider | 4,167 | $3.95 | Sell | $16,459.65 | |
Oct. 3, 2022 | General Counsel | 4,563 | $3.95 | Sell | $18,023.85 | |
Oct. 3, 2022 | CTO | 2,455 | $3.95 | Sell | $9,697.25 | |
Oct. 3, 2022 | CFO | 4,901 | $3.95 | Sell | $19,358.95 | |
Oct. 3, 2022 | EVP | 12,524 | $3.92 | Sell | $49,094.08 | |
Sept. 30, 2022 | General Counsel | 3,725 | $4.07 | Sell | $15,160.75 | |
Sept. 30, 2022 | EVP | 2,468 | $4.07 | Sell | $10,044.76 | |
Sept. 30, 2022 | Insider | 3,401 | $4.07 | Sell | $13,842.07 | |
Sept. 30, 2022 | CFO | 4,000 | $4.07 | Sell | $16,280.00 | |
Sept. 30, 2022 | CTO | 2,003 | $4.07 | Sell | $8,152.21 | |
Aug. 1, 2022 | EVP | 10,423 | $4.45 | Sell | $46,382.35 | |
July 18, 2022 | EVP | 20,000 | $4.87 | Sell | $97,400.00 | |
July 1, 2022 | EVP | 9,100 | $5.03 | Sell | $45,773.00 | |
June 24, 2022 | CEO | 10,000 | $4.63 | Buy | $46,300.00 | |
June 17, 2022 | EVP | 9,200 | $4.68 | Sell | $43,056.00 | |
May 17, 2022 | EVP | 20,222 | $5.42 | Sell | $109,603.24 | |
Feb. 2, 2022 | CEO | 5,000 | $9.74 | Buy | $48,700.00 | |
Jan. 28, 2022 | Insider | 27,500 | $9.05 | Buy | $248,875.00 | |
Dec. 2, 2021 | Major Shareholder | 34,326 | $12.82 | Buy | $440,059.32 | |
Dec. 1, 2021 | Director | 60,304 | $12.62 | Buy | $761,036.48 | |
Nov. 30, 2021 | Major Shareholder | 36,847 | $11.62 | Buy | $428,162.14 | |
Nov. 29, 2021 | Director | 56,706 | $11.70 | Buy | $663,460.20 | |
Nov. 26, 2021 | Director | 11,817 | $11.34 | Buy | $134,004.78 | |
Nov. 18, 2021 | Director | 10,000 | $11.98 | Buy | $119,800.00 | |
Nov. 16, 2021 | Insider | 5,000 | $12.46 | Buy | $62,300.00 | |
Nov. 16, 2021 | CEO | 23,000 | $12.28 | Buy | $282,440.00 |
Insiders are both buying and selling Centessa Pharmaceuticals PLC ADR stock.
The insider traders at Centessa Pharmaceuticals PLC ADR are: Saurabh Saha, Gregory M Weinhoff, Antoine Yver, Iqbal J Hussain, Karen M Anderson, Tia L Bush, Rubertis Francesco De, David M Chao, Harris Rotman, Medicxi Ventures Management (J, Arjun Goyal, Thomas Templeman, Mario Alberto Accardi, Aaron Kantoff, and David J Grainger
The most active insider trader at Centessa Pharmaceuticals PLC ADR is Saurabh Saha with 20 trades.
Saurabh Saha has sold the most Centessa Pharmaceuticals PLC ADR stock with a total value of $12,717,427.11.
Arjun Goyal has bought the most Centessa Pharmaceuticals PLC ADR stock with a total value of $11,183,320.52.
The most recent insider trade for Centessa Pharmaceuticals PLC ADR was on June 25, 2025.
The single biggest insider buy for Centessa Pharmaceuticals PLC ADR was from Arjun Goyal with a total value of $5,316,633.58 on May 16, 2025.
The single biggest insider sell for Centessa Pharmaceuticals PLC ADR was from Saurabh Saha with a total value of $2,891,000.00 on Sept. 10, 2024.